At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 291 enrolled
Drug / intervention
V120083 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of V120083 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
In Brief
A Phase 2 clinical trial evaluating V120083, Naproxen, and 1 other intervention for Osteo Arthritis Knee. Completed, enrolled 291 participants across 30 sites.
Detailed Summary
The purpose of this study is to evaluate the analgesic efficacy of V120083 twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteo Arthritis Knee
CountriesUnited States
CollaboratorsShionogi
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartMar 2017
Primary CompletionNov 2017
Study CompletionNov 2017
TodayJul 2026
First PostedJan 23, 2017
Enrollment StartMar 14, 2017
Primary CompletionNov 10, 2017
Study CompletionNov 21, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.4 years ago
Interventions
V120083drug
Capsules
Naproxendrug
Capsules
Placebodrug
Capsules to match V120083 and/or naproxen